MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$82K
Free Cash flow
$4,104K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the sale and matur...
Net income (loss)
Omidria contract royalty asset
Others
Negative Cash Flow Breakdown
Remeasurement on fair value of f...
Purchases of investments
Receivables
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
13,232
56,060
86,451
-30,917
Stock-based compensation expense
1,621
1,889
1,733
1,941
Loss on early extinguishment of 2026 notes
-
-
-
0
(gain) loss on early extinguishment of debt-Convertible Senior Notes2026
-
-
-2,968
-
Amortization of discount and issuance costs-Convertible Debt
1,437
1,460
1,479
1,478
Loss on early extinguishment of notes-The2029Notes
-1,896
-
-
-
Depreciation and amortization
193
239
235
240
Gain on sale of zaltenibart
-
-
237,594
-
Loss on early extinguishment of notes-Convertible Senior Notes2026
0
-
-
-
Remeasurement of omidria contract royalty asset
-
32,552
-
-22,293
Remeasurement on fair value of financial instruments
11,447
73,146
-136,037
-8,822
Non-cash interest on omidria contract royalty asset
3,063
3,132
3,196
3,682
Remeasurement of omidria contract royalty asset
-5,191
-
-3,726
13,402
(gain) loss on early extinguishment of debt-Initial Term Loan
-
-
20,579
-
Amortization of discount and issuance costs-Loans Payable
-
4,727
-
-1,513
Non-cash interest remeasurement on omidria royalty obligation
557
-1,410
-33,435
-
Accretion on u.s. government treasury bills, net
-
-
0
0
Amortization of discount and issuance costs-Initial Term Loan
0
-
-5,578
-
Omidria contract royalty asset
-9,351
-7,343
-9,219
-9,153
Prepaid expenses and other
-1,650
-87
4,024
-2,398
Receivables
9,269
1,115
4,009
632
Inventory
659
183
-
-
Accounts payable and accrued expense
2,222
-979
-1,753
3,130
Net cash used in operating activities
4,149
-14,506
-39,842
-18,473
Gross cash proceeds from sale of zaltenibart
-
-
240,000
-
Proceeds from the sale and maturities of investments
13,600
30,050
38,400
10,500
Purchases of investments
10,155
1,316
166,854
17,350
Purchases of property and equipment
45
0
0
11
Net cash provided by investing activities
3,400
28,734
111,546
-6,861
Proceeds from registered offering, net-Securities Purchase Agreement With Polar Asset Management
-
-
0
20,327
Proceeds from registered offering, net-At The Market Equity Offering Program
-
-
3,724
15,292
Proceeds upon exercise of stock options
-
-
7,651
-
Exercise of stock options
2,858
7,895
-
225
Proceeds from sale of future royalties
-
-
0
0
Repayment of 2026 notes
0
17,077
67,077
-
Payment on maturity of 2023 notes
-
-
0
-
Principal payments on omidria royalty obligation
4,462
4,670
4,700
3,555
Cash paid to repurchase 2026 notes
-
-
0
0
Prepayment premium and transaction costs on repayment of term debt-Initial Term Loan
-
-
3,544
-
Repurchases of common stock
5,726
4,152
0
0
Payment of debt issuance costs related to 2029 notes-The2029Notes
-
-
2,837
-
Net share settlement of equity awards
0
4,108
-
-
Payments on finance lease obligations
137
183
180
177
Proceeds from issuance of common stock from the atm facility, net
0
-
-
-
Payment of debt issuance costs related to 2029 notes
-2,837
-
-
0
Net cash used in financing activities
-7,467
-21,982
-64,439
25,825
Net increase (decrease) in cash and cash equivalents
82
-7,754
7,265
491
Cash and cash equivalents at beginning of period
1,906
9,660
2,395
3,400
Cash and cash equivalents at end of period
1,988
1,906
9,660
2,395
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income (loss)
$13,232K
(122.47%↑ Y/Y)
Proceeds from the sale and
maturities of investments
$13,600K
(-77.70%↓ Y/Y)
Omidria contract
royalty asset
-$9,351K
(38.69%↑ Y/Y)
Accounts payable and
accrued expense
$2,222K
(-30.67%↓ Y/Y)
Loss on early
extinguishment of...
-$1,896K
Prepaid expenses and
other
-$1,650K
(-423.81%↓ Y/Y)
Stock-based compensation
expense
$1,621K
(-64.12%↓ Y/Y)
something is missing
$1,619K
Amortization of discount and
issuance...
$1,437K
(45.45%↑ Y/Y)
Non-cash interest
remeasurement on omidria...
$557K
Depreciation and
amortization
$193K
(-60.53%↓ Y/Y)
Net cash used in
operating activities
$4,149K
(107.18%↑ Y/Y)
Net cash provided by
investing activities
$3,400K
(-94.32%↓ Y/Y)
Canceled cashflow
$29,629K
Canceled cashflow
$10,200K
Net increase
(decrease) in cash and cash...
$82K
(105.48%↑ Y/Y)
Canceled cashflow
$7,467K
Remeasurement on fair value of
financial instruments
$11,447K
(40.59%↑ Y/Y)
Receivables
$9,269K
(733.56%↑ Y/Y)
Remeasurement of omidria
contract royalty asset
-$5,191K
(-274.14%↓ Y/Y)
Non-cash interest on
omidria contract...
$3,063K
(-60.93%↓ Y/Y)
Inventory
$659K
Exercise of stock options
$2,858K
(3147.73%↑ Y/Y)
Payment of debt issuance
costs related to 2029...
-$2,837K
(-200.00%↓ Y/Y)
Purchases of investments
$10,155K
(816.52%↑ Y/Y)
Purchases of property and
equipment
$45K
(-16.67%↓ Y/Y)
Net cash used in
financing activities
-$7,467K
(-110.04%↓ Y/Y)
Canceled cashflow
$5,695K
Repurchases of common stock
$5,726K
Principal payments on
omidria royalty...
$4,462K
(-33.41%↓ Y/Y)
something is missing
-$2,837K
Payments on finance lease
obligations
$137K
(-65.05%↓ Y/Y)
Buy us a coffee
OMEROS CORP (OMER)
OMEROS CORP (OMER)